Finch Trades

As of market close
March 6, 2026
Update frequency: every Saturday morning
Transaction
Position
Overall
Group
Year
Company
An icon graphic of an arrow.
Ticker
An icon graphic of an arrow.
Entry Date
An icon graphic of an arrow.
Group
An icon graphic of an arrow.
Status
An icon graphic of an arrow.
Cost Basis
An icon graphic of an arrow.
Last Price
An icon graphic of an arrow.
Principal
An icon graphic of an arrow.
Last Value
An icon graphic of an arrow.
% Change
An icon graphic of an arrow.
vs. SPY
An icon graphic of an arrow.
Click individual row to view transaction details
Coherus Oncology
$CHRS
3/6/26
Future Compounder
Active
Exited
9992
$1.75
$1.82
$2,500
$2,600
4.0%
4.3%
Codexis
$CDXS
3/2/26
Future Compounder
Active
Exited
9993
$1.00
$1.23
$1,000
$1,230
23.0%
25.0%
Harmony Biosciences
$HRMY
2/20/26
Opportunistic
Active
Exited
9994
$30.75
$28.50
$1,750
$1,622
-7.3%
-7.4%
Harmony Biosciences
$HRMY
5/2/25
Current Compounder
Active
Exited
9995
$30.00
$28.50
$23,245
$22,083
-5.0%
-25.7%
Exact Sciences
$EXAS
4/30/25
Opportunistic
Active
Exited
9999
$44.69
$53.05
$10,000
$11,871
18.7%
14.9%
Blueprint Medicines
$BPMC
4/30/25
Opportunistic
Active
Exited
10000
$88.21
$98.73
$10,000
$11,193
11.9%
8.9%
Coherus Oncology
$CHRS
3/27/25
Future Compounder
Active
Exited
$0.86
$1.82
$250
$530
111.8%
93.3%
Coherus Oncology
$CHRS
1/21/25
Future Compounder
Active
Exited
$1.37
$1.82
$1,000
$1,328
32.8%
21.4%
Relay Therapeutics
$RLAY
1/10/25
Future Compounder
Active
Exited
$4.32
$9.89
$7,000
$16,033
129.0%
113.2%
AVITA Medical
$RCEL
1/8/25
Future Compounder
Active
Exited
9998
$9.53
$7.45
$1,000
$782
-21.8%
-18.5%
Relay Therapeutics
$RLAY
12/10/24
Future Compounder
Active
Exited
$4.44
$9.89
$2,500
$5,563
122.5%
111.0%
Relay Therapeutics
$RLAY
12/3/24
Future Compounder
Active
Exited
$4.45
$9.89
$2,500
$5,562
122.5%
111.2%
Relay Therapeutics
$RLAY
11/20/24
Future Compounder
Active
Exited
$4.55
$9.89
$2,000
$4,348
117.4%
103.5%
Relay Therapeutics
$RLAY
10/29/24
Future Compounder
Active
Exited
$5.80
$9.89
$1,000
$1,707
70.7%
55.1%
Arrowhead Pharma
$ARWR
10/1/24
Future Compounder
Active
Exited
9996
$18.48
$63.64
$1,000
$3,444
244.4%
224.2%
Relay Therapeutics
$RLAY
9/25/24
Future Compounder
Active
Exited
$7.00
$9.89
$725
$1,024
41.3%
23.3%
Arrowhead Pharma
$ARWR
9/25/24
Future Compounder
Active
Exited
9997
$19.48
$63.64
$1,000
$3,268
226.8%
206.9%
Relay Therapeutics
$RLAY
9/13/24
Future Compounder
Active
Exited
$7.55
$9.89
$1,000
$1,310
31.0%
11.4%
Relay Therapeutics
$RLAY
9/5/24
Future Compounder
Active
Exited
$6.18
$9.89
$2,000
$3,201
60.0%
37.7%
Coherus Oncology
$CHRS
7/2/24
Future Compounder
Active
Exited
$1.40
$1.82
$1,000
$1,305
30.5%
8.0%
Exact Sciences
$EXAS
5/29/24
Current Compounder
Active
Exited
$44.98
$103.50
$1,000
$2,301
130.1%
102.3%
Relay Therapeutics
$RLAY
5/29/24
Future Compounder
Active
Exited
$6.28
$9.89
$1,000
$1,576
57.6%
29.8%
Coherus Oncology
$CHRS
4/25/24
Future Compounder
Active
Exited
$1.93
$1.82
$6,996
$6,598
-5.7%
-39.2%
Position
An icon graphic of an arrow.
Ticker
An icon graphic of an arrow.
Group
An icon graphic of an arrow.
Status
An icon graphic of an arrow.
Shares
An icon graphic of an arrow.
Cost Basis
An icon graphic of an arrow.
Last Price
An icon graphic of an arrow.
Principal
An icon graphic of an arrow.
Last Value
An icon graphic of an arrow.
% Change
An icon graphic of an arrow.
vs. SPY
An icon graphic of an arrow.
Click individual row to view position details
Relay Therapeutics
$RLAY
Future Compounder
Building
Building
Building
1
4,077.2
$4.84
$9.89
$19,725
$40,324
104.4%
88.4%
Coherus Oncology
$CHRS
Future Compounder
Building
Building
Building
2
6,791.3
$1.73
$1.82
$11,746
$12,360
5.2%
-18.0%
Codexis
$CDXS
Future Compounder
Building
Building
Building
3
1,000.0
$1.00
$1.23
$1,000
$1,230
23.0%
25.0%
Exact Sciences
$EXAS
Current Compounder
Full
Full
Full
994
22.2
$44.98
$103.50
$1,000
$2,301
130.1%
102.3%
Harmony Biosciences
$HRMY
Opportunistic
Exited
Exited
Exited
995
56.9
$30.75
$28.50
$1,750
$1,622
-7.3%
-7.4%
Harmony Biosciences
$HRMY
Current Compounder
Exited
Exited
Exited
996
774.8
$30.00
$28.50
$23,245
$22,083
-5.0%
-25.7%
Arrowhead Pharma
$ARWR
Future Compounder
Exited
Exited
Exited
997
105.5
$18.96
$63.64
$2,000
$6,712
235.6%
206.9%
AVITA Medical
$RCEL
Future Compounder
Exited
Exited
Exited
998
104.9
$9.53
$7.45
$1,000
$782
-21.8%
-18.3%
Exact Sciences
$EXAS
Opportunistic
Exited
Exited
Exited
999
223.8
$44.69
$53.05
$10,000
$11,871
18.7%
14.9%
Blueprint Medicines
$BPMC
Opportunistic
Exited
Exited
Exited
1000
113.4
$88.21
$98.73
$10,000
$11,193
11.9%
8.9%
Principal
$53,153
Current Value
$82,163
Total Return
54.6%
CAGR
(from April 2024)
26.4%
Benchmark
An icon graphic of an arrow.
Ticker
An icon graphic of an arrow.
Principal
An icon graphic of an arrow.
Current Value
An icon graphic of an arrow.
$ Change
An icon graphic of an arrow.
% Change
An icon graphic of an arrow.
Finch Trades vs.
An icon graphic of an arrow.
Finch Trades
$FINCH
$53,153
$82,163
$29,010
54.6%
0.0%
If S&P 500
$SPY
$53,153
$64,167
$11,014
20.7%
33.9%
If XBI
$XBI
$53,153
$74,408
$21,256
40.0%
14.6%
If Nasdaq 100
$QQQ
$53,153
$66,738
$13,585
25.6%
29.0%
If ARKG
$ARKG
$53,153
$62,865
$9,712
18.3%
36.3%
Group
An icon graphic of an arrow.
Principal
An icon graphic of an arrow.
Last Value
An icon graphic of an arrow.
% Change
An icon graphic of an arrow.
vs. SPY
An icon graphic of an arrow.
vs. QQQ
An icon graphic of an arrow.
vs. XBI
An icon graphic of an arrow.
vs. ARKG
An icon graphic of an arrow.
Future Compounder
$35,471
$61,408
73.1%
55.5%
51.2%
41.9%
60.2%
Opportunistic
$21,750
$24,686
13.5%
10.3%
11.6%
13.3%
13.0%
Current Compounder
$24,245
$24,384
0.6%
-20.5%
-23.9%
-51.1%
-31.0%
* This view tracks performance by the portfolio allocation group without accounting for reinvested proceeds.
Year
An icon graphic of an arrow.
Principal
An icon graphic of an arrow.
Last Value
An icon graphic of an arrow.
% Change
An icon graphic of an arrow.
vs. SPY
An icon graphic of an arrow.
vs. QQQ
An icon graphic of an arrow.
vs. XBI
An icon graphic of an arrow.
vs. ARKG
An icon graphic of an arrow.
2024
$23,721
$41,206
73.7%
51.3%
45.6%
38.1%
57.7%
2025
$52,495
$63,819
21.6%
8.7%
7.4%
-7.3%
5.3%
2026
$5,250
$5,452
3.8%
4.3%
4.0%
2.9%
4.0%
* This view tracks performance by the year principal was invested without accounting for reinvested proceeds.
Research Notes
MOS Dashboard
ABOUT
What Is Solt DB?
Public Benefit
Our Lonely Team
PUBLIC CONTENT
Articles
Data Visualizations
Newsletter
INVESTING
Pricing
Member Benefits
Stocks We Cover
CONTACT
Questions?
Critiques?
Love letters?

Reach out here.
About Solt DB

Solt DB is an equities research firm and public benefit company exploring the business of biotech. For scientists, investors, and nerds of all stripes – or feathers.

Yinz respect the finch n@. 2026 Solt DB.
A white logo of LinkedIn.